Gilead to boost West Coast production muscle after revealing New Jersey layoffs

As Gilead Sciences slims down on the East Coast, the company is plotting manufacturing moves out West.

The biotech has closed a deal for 27 acres of undeveloped land near its existing facility in Oceanside, California, which it will use to stand up additional manufacturing in the area, Joydeep Ganguly, Gilead’s senior vice president of corporate operations, said in a statement. The company’s current Oceanside outfit supports clinical manufacturing and process development for Gilead and Kite Pharma, the exec said.